NCT01010932View on ClinicalTrials.gov

Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

PHASE3CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Cerebral Arterial Diseases
Interventions
DRUG

Dotarem

Each subject will receive one injection of Dotarem 0.2ml/kg

OTHER

TOF MRA

Each subject will undergo a Time of Flight Magnetic Resonance Angiography (TOF MRA)

Trial Locations (1)

47403

Guerbet LLC, Bloomington

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT01010932 - Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) | Biotech Hunter | Biotech Hunter